Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

A1. Novel Agents

Poster Session: Novel Agents

(P-1107) Oral Sulopenem/probenecid for Uncomplicated Urinary Tract Infections (uUTI): Results from the REASSURE Trial

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Presenting Author(s)

  • Sailaja Puttagunta, MD

    Chief Medical Officer
    Iterum Therapeutics
    Old Saybrook, Connecticut, United States

    • Co-Author(s)

  • Steven I. Aronin, MD

    Senior Vice President and Head of Clinical Development
    Iterum Therapeutics
    Old Saybrook, CT, United States

  • JG

    Jayanti Gupta, PhD

    Iterum Therapeutics
    Old Saybrook, Connecticut, United States

  • AD

    Anita F. Das, PhD

    Statistician
    Das Consulting
    Guerneville, CA, United States

  • Kalpana Gupta, MD

    Chief, Section of Infectious Diseases at the Veterans Administration Boston Healthcare System, and Professor of Medicine at Chobanian and Avedisian School of Medicine
    Boston University School of Medicine
    Boston, Massachusetts, United States

  • Michael W. Dunne, MD

    Chief Scientific Officer
    Iterum Therapeutics
    Old Saybrook, CT, United States